“Structure-Based Design and Computational Validation of Novel 1,3,4-Thiadiazole-Peptide Conjugates As Selective Cyclin-Dependent Kinase-2 (CDK2) Inhibitors for Lung Cancer Therapy”. Pakistan Journal of Medical & Cardiological Review, vol. 5, no. 2, Apr. 2026, pp. 1174-80, https://doi.org/10.66021/pakmcr903.